Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
182004-64-4 (free base)
Metastatic Castration-Resistant Prostate Cancer: Critical Review of MDV-3100
J Neurosci Res
FOY-251 inhibits the proteolytic activity of prostasin
Dapagliflozin chin gallate 182004-64-4 (free base)Dapagliflozin, also known as BMS 512148, is a drug used to treat type 2 diabetes approved in 2012 by FDA. Dapagliflozin inhibits subtype 2 of the sodium glucose transport proteins (SGLT2) which are responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter mechanism causes blood glucose to be eliminated through the urine. In clinical trials, dapagliflozin lowered HbA1c by 0. 6 versus placebo percentage points
US$ 395.00
US$ 550.00
US$ 1400.00
US$ 26.00
US$ 700.00
US$ 1800.00
US$ 18.00
US$ 550.00
US$ 39.99
US$ 65.99
US$ 65.99
US$ 34.99
US$ 46.99
US$ 290.00
US$ 260.00
US$ 290.00